-+ 0.00%
-+ 0.00%
-+ 0.00%

BELITE BIO - APPLICATION TO UNDERGO 60-DAY FDA REVIEW; PDUFA DATE TO BE ASSIGNED IF ACCEPTED

Reuters·06/13/2026 01:30:00

Please log in to view news